Evidence map›Paper›PMID 42172100›Full record

ArticleFEMS microbiology letters2026

Disrupting the mtr-operon in Methanosarcina acetivorans enables methyl-reducing methanogenesis with hydrogen and serine as the alternative electron donors.

Jichen Bao, Tejas Somvanshi, Yufang Tian, Silvan Scheller

Abstract read
In one paragraph

Article in FEMS microbiology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jichen BaoDepartment of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, Kemistintie 1, 02150 Espoo, Finland.
Tejas SomvanshiDepartment of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, Kemistintie 1, 02150 Espoo, Finland.ORCID 0009-0000-5117-1625
Yufang TianDepartment of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, Kemistintie 1, 02150 Espoo, Finland.
Silvan SchellerDepartment of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, Kemistintie 1, 02150 Espoo, Finland.ORCID 0000-0002-0667-9224

Funding

Business Finland 2616/31/2023NovoNordisk Foundation Center for Basic Metabolic Research NNF19OC0054329
6 · The paper itself

Abstract

Methanosarcina acetivorans is a model methanogen because of its metabolic versatility and genetic tractability. This microbe is not known to natively utilize hydrogen as a catabolic electron donor, despite its genome encoding hydrogenases, and the fact that this microbe can be used to heterologously express functional hydrogenases. Its native hydrogenases are expressed at a very low level and are suggested to have a role in recycling hydrogen that is produced as a byproduct of nitrogen fixation. To explore whether hydrogen can act as a catabolic electron donor, we utilized a previously constructed strain (str. JB-MF) that has the operon encoding for the methyl-H4MPT:CoM methyltransferase (Mtr) disrupted which makes growth dependent on oxidation of electron donors other than methanol. We showed that this M. acetivorans strain can grow by methanol reduction to methane with hydrogen as the sole electron donor. The strain was then used to test the putative electron donors for methyl-reducing methanogenesis: hydrogen, serine, and ethanol. Hydrogen and serine were identified to act as catabolic electron donors for methyl-reducing methanogenesis, which demonstrates the expanded metabolic versatility of M. acetivorans JB-MF. The methanophenazine-reducing hydrogenase (Vht) and the F420-reducing hydrogenase (Frh) were determined to be involved in hydrogen metabolism, because deletion of either made M. acetivorans JB-MF incapable of growing using H2-dependent methyl-reduction. We demonstrate that strain JB-MF is a suitable chassis to screen alternative electron donors for methanogenesis and that this strain may be used for targeted directed evolution of oxidoreductases.

Indexed as

HydrogenMethaneMethanosarcinaMethyltransferasesOperonSerineHydrogenaseMethanolOxidation-ReductionHydrogenHydrogenaseMethaneMethanolMethyltransferasesSerinehydrogenaseshydrogensmethanosarcina acetivoransmmethyl-reducing methanogenesishserine

Identifiers

PMID42172100
PMCPMC13224831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.